YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Establishment of Dissolution Specifications for Octylonium Bromide Tablets and Pinaverium Bromide Tablets

브롬화옥틸로늄 정과 브롬화피나베륨 정의 용출규격 설정

  • Lee, Ryun-Kyung (Hazardous Substances Analysis Division, Daegu Regional Food & Drug Administration) ;
  • Lee, Yoon-Ae (Hazardous Substances Analysis Division, Daegu Regional Food & Drug Administration) ;
  • Shim, Jee-Youn (Hazardous Substances Analysis Division, Daegu Regional Food & Drug Administration) ;
  • Kim, Min-A (Hazardous Substances Analysis Division, Daegu Regional Food & Drug Administration) ;
  • Sohn, Kyung-Hee (National Institute of Food and Drug Safety Evaluation, Osong Health Technology Administration Complex) ;
  • Park, Hye-Rim (Korea Food & Drug Administration, Osong Health Technology Administration Complex) ;
  • Kim, Hee-Sung (Korea Food & Drug Administration, Osong Health Technology Administration Complex) ;
  • Song, Young-Mi (Korea Food & Drug Administration, Osong Health Technology Administration Complex) ;
  • Lee, Su-Jung (Korea Food & Drug Administration, Osong Health Technology Administration Complex) ;
  • Sah, Hong-Kee (College of Pharmacy, Ewha Womans University) ;
  • Choi, Hoo-Kyun (College of Pharmacy, Chson University) ;
  • Kim, Young-Ok (Korea Food & Drug Administration, Osong Health Technology Administration Complex) ;
  • Kim, Dong-Sup (National Institute of Food and Drug Safety Evaluation, Osong Health Technology Administration Complex) ;
  • Cho, Tae-Yong (Hazardous Substances Analysis Division, Daegu Regional Food & Drug Administration)
  • 이륜경 (대구지방식품의약품안전청 유해물질분석과) ;
  • 이윤애 (대구지방식품의약품안전청 유해물질분석과) ;
  • 심지연 (대구지방식품의약품안전청 유해물질분석과) ;
  • 김민아 (대구지방식품의약품안전청 유해물질분석과) ;
  • 손경희 (식품의약품안전평가원) ;
  • 박혜림 (식품의약품안전청) ;
  • 김희성 (식품의약품안전청) ;
  • 송영미 (식품의약품안전청) ;
  • 이수정 (식품의약품안전청) ;
  • 사홍기 (이화여자대학교 약학대학) ;
  • 최후균 (조선대학교 약학대학) ;
  • 김영옥 (식품의약품안전청) ;
  • 김동섭 (식품의약품안전평가원) ;
  • 조태용 (대구지방식품의약품안전청 유해물질분석과)
  • Received : 2011.08.05
  • Accepted : 2011.09.21
  • Published : 2011.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

To secure the good quality of pharmaceutical products, dissolution specifications for Octylonium bromide tablets and Pinaverium bromide tablets are needed to be established, which are enrolled in KPC (Korea Pharmaceutical Codex) with having no appropriate specifications. For establishing dissolution specifications, a number of experiments based on the "Guideline of Dissolution Testing for Solide Oral Dosage Forms" were performed. The results of this study will be used for revising KPC and it is expected to contribute to the incessant production of quality ensured drugs.

Keywords

References

  1. 식품의약품안전청 연구개발사업 : 고시수재 의약품의 용출규격 설정에 관한 연구, 김영옥 등 (2009).
  2. 식품의약품안전청 : 대한약전 의약품등 기준 제 3개정 (2007).
  3. 식품의약품안전청 용역연구개발사업 : 의약품 동등성 재평가 대상 성분의 생동성 평가방법에 관한 연구(브롬화옥틸로늄), 강원구 등 (2006).
  4. de Weerdt, G. A., Beke, R. P., Verdievel, H. G., Barbier, F., Jonckheere, J. A. and de Leenheer, A. P.: Quantitative gas chromatographic mass spectrometric determination of pinaverium-bromide in human serum. Biomed. Mass Spectrum. 10, 162 (1983). https://doi.org/10.1002/bms.1200100310
  5. Lu, C. L., Chen, C. Y., Chang, F. Y., Chang, S. S., Kang, L. J., Lu, R. H. and Lee, S. D. : Effect of a calcium channel blocker and antispasmodic in diarrhea-predominant irritable bowel syndrome. J. Gastrsenterol. Hepatol. 15, 925 (2000). https://doi.org/10.1046/j.1440-1746.2000.02230.x
  6. Bouchoucha, M., Faye, A., Devroede, G. and Arsac, M. : Effect of oral pinaverium bromide on colonic response to food in irritable bowel syndrome patients. Biomed. Pharmacother. 54, 381 (2000). https://doi.org/10.1016/S0753-3322(01)80005-6
  7. Scarpignato, C. and Pelosini, I. : Management of irritable bowel syndrome, novel approaches to the pharmacology of gut motility. Can. J. Gastroenterol. 13, 50A (1999) https://doi.org/10.1155/1999/183697
  8. Dai, Y., Liu, J. X., Li, J. X. and Xu, Y. F. : Effect of pinaverium bromide on stress-induced colonic smooth muscle contractility disorder in rats. World J. Gastroenterol. 9, 557 (2003). https://doi.org/10.3748/wjg.v9.i3.557
  9. 식품의약품안전청 용역연구개발사업 : 브롬화피나베리움의 생체이 용률시험 및 생물학적동등성시험 표준지침 작성, 한상범 등 (2004).
  10. 대한약전 9개정 : 경구용의약품의 용출규격 설정 지침 (2007).
  11. 식품의약품안전청 고시 : 의약품동등성시험관리규정 (2005).
  12. 대한약전 9개정 : 의약품등 분석법의 밸리데이션에 대한 지침 (2007).